The FDA has had a busy December 2025, with several notable new drug approvals. Eli Lilly’s Zepbound became the first FDA-approved medicine for chronic sleep apnea. Meanwhile, drugs for rare diseases were also given the go-ahead, including a treatment by Ionis Pharmaceuticals for a rare metabolic disorder and Humacyte’s bioengineered blood vessel for trauma patients. Finally, the FDA approval was granted to the first cell therapy from mesenchymal stromal cells by Mesoblast for graft versus host disease.
Anne Arundel government has made progress in securing systems since cyber incident, officials say – CBS News
Anne Arundel County government officials have reported making progress in securing systems following a cyber incident. Specific details of the incident were not provided, but
